APA

Chioato A., Noseda E., Stevens M., Gaitatzis N., Kleinschmidt A. & Picaud H. (20130405). Treatment with the interleukin-17A-blocking antibody secukinumab does not interfere with the efficacy of influenza and meningococcal vaccinations in healthy subjects: results of an open-label, parallel-group, randomized single-center study. : Clinical and vaccine immunology : CVI.

Chicago

Chioato A, Noseda E, Stevens M, Gaitatzis N, Kleinschmidt A and Picaud H. 20130405. Treatment with the interleukin-17A-blocking antibody secukinumab does not interfere with the efficacy of influenza and meningococcal vaccinations in healthy subjects: results of an open-label, parallel-group, randomized single-center study. : Clinical and vaccine immunology : CVI.

Harvard

Chioato A., Noseda E., Stevens M., Gaitatzis N., Kleinschmidt A. and Picaud H. (20130405). Treatment with the interleukin-17A-blocking antibody secukinumab does not interfere with the efficacy of influenza and meningococcal vaccinations in healthy subjects: results of an open-label, parallel-group, randomized single-center study. : Clinical and vaccine immunology : CVI.

MLA

Chioato A, Noseda E, Stevens M, Gaitatzis N, Kleinschmidt A and Picaud H. Treatment with the interleukin-17A-blocking antibody secukinumab does not interfere with the efficacy of influenza and meningococcal vaccinations in healthy subjects: results of an open-label, parallel-group, randomized single-center study. : Clinical and vaccine immunology : CVI. 20130405.